TAMAR HOWSON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

IMMUNIC, INC.

Filing Date Source Excerpt
2024-02-05 Tamar Howson, Director

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2010-11-12 Tamar Howson 50,000 *
2011-02-18 Tamar Howson
2012-11-19 Tamar Howson(2) 86,060 * Includes options to purchase 48,000 shares of common stock, which are exercisable on November 1, 2012 or within 60 days thereafter.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22